{'fraction_non_alphanumeric': 0.02029769959404601, 'fraction_numerical': 0.008119079837618403, 'mean_word_length': 5.3247863247863245, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Recurrent urinary tract infections: a critical review of the currently available treatment options

Urinary tract infections (UTIs) are the most common infections in women worldwide. Prevalence increases with age to 20% over the age of 60. Recurrence is common. UTI is a clinical and socio‐economic burden and a cause of significant psychological distress to the patient. Acute UTI needs swift assessment, diagnosis and treatment to prevent ascending or systemic infection. Antibiotics remain the mainstay of treatment in acute UTI; it is thought that up to 50% of antibiotic prescriptions are inappropriate or unnecessary and may increase the risk of bacterial resistance. Management strategies to prevent recurrent UTI are heterogeneous.